Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to 0.78.

  • Firefly Neuroscience's Equity Ratio rose 24896.66% to 0.78 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.78, marking a year-over-year increase of 24896.66%. This contributed to the annual value of 0.08 for FY2024, which is 29747.9% down from last year.
  • Latest data reveals that Firefly Neuroscience reported Equity Ratio of 0.78 as of Q3 2025, which was up 24896.66% from 0.81 recorded in Q2 2025.
  • Firefly Neuroscience's 5-year Equity Ratio high stood at 0.81 for Q2 2025, and its period low was 0.52 during Q3 2024.
  • For the 5-year period, Firefly Neuroscience's Equity Ratio averaged around 0.31, with its median value being 0.42 (2023).
  • Per our database at Business Quant, Firefly Neuroscience's Equity Ratio crashed by 29747.9% in 2024 and then soared by 1764346.64% in 2025.
  • Quarter analysis of 5 years shows Firefly Neuroscience's Equity Ratio stood at 0.75 in 2021, then plummeted by 137.36% to 0.28 in 2022, then skyrocketed by 114.8% to 0.04 in 2023, then plummeted by 297.48% to 0.08 in 2024, then surged by 1054.98% to 0.78 in 2025.
  • Its Equity Ratio was 0.78 in Q3 2025, compared to 0.81 in Q2 2025 and 0.42 in Q1 2025.